insulin detemir

FDA Drug Profile — Levemir, LEVEMIR

insulin detemir is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand names including Levemir, LEVEMIR. Available dosage forms: powder, injection, solution.

Drug Details

Generic Name
insulin detemir
Brand Names
Levemir, LEVEMIR
Application Number
BLA021536
Sponsor
Virtu Pharmako (Zhejiang) Co., Ltd.
NDC Codes
8
Dosage Forms
POWDER, INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
INSULIN DETEMIR

Indications and Usage

1 INDICATIONS AND USAGE LEVEMIR is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. Limitations of Use LEVEMIR is not recommended for the treatment of diabetic ketoacidosis. LEVEMIR is a long-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus ( 1 ). Limitations of Use: Not recommended for the treatment of diabetic ketoacidosis.